Objective: To synthesize the best evidence surrounding the efficacy of cannabinoids for
acute pain in the clinical setting based on subjective pain scores and observed adverse …

The scientific basis for supporting the use of cannabis is extensive, although it does not
necessarily translate into relevant clinical outcomes. The use of cannabinoids in acute pain …

Background Cannabinergic medications have been postulated to demonstrate efficacy in
the management of pain. The aim of this systematic review was to assess the analgesic …

Introduction Pain is a global phenomenon encompassing many subtypes that include
neuropathic, musculoskeletal, acute postoperative, cancer, and geriatric pain. Traditionally …

Abstract Introduction The IASP ICD-11 chronic primary pain (CPP) definition includes 19
different painful conditions. In recent years, interest in the potential role of cannabinoids in …

Chronic pain states have resulted in an overreliance on opioid pain relievers, which can
carry significant risks when used long term. As such, alternative pain treatments are …

Objectives To assess the benefits and harms of cannabinoids in participants with pain.
Design Systematic review of randomised clinical trials with meta-analysis, Trial Sequential …

Cannabinoids have been used for thousands of years to provide relief from suffering, but
only recently have they been critically evaluated in clinical trials. This review provides an in …

Pain is an experience that affects many people worldwide and is associated with higher
mortality and lower quality of life. Cannabinoid, cannabis, and cannabis-based medicines …

Over the past five years, there has been a considerable increase in clinical research on
cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming …